Article
Involvement of ribosomal protein L11 expression in sensitivity of gastric cancer against 5‑FU
24 Jan 2020
Abstract excerpt
5‑Fluorouracil (5‑FU) is widely used in the treatment of various types of solid cancer. Our study showed that ribosomal protein L11 (RPL11) was a crucial factor affecting sensitivity of gastric cancer to 5‑FU, implying that RPL11 expression is a potential biomarker for predicting 5‑FU sensitivity. Kaplan‑Meier survival analysis indicated that high RPL11 expression in gastric cancer patients treated with 5‑FU was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
